THU-133-Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience
Velia Chiara Di Maio(University of Rome Tor Vergata), Giustino Parruti(Azienda USL di Pescara), Miriam Lichtner(Sapienza University of Rome), L. Donnarumma(University of Naples Federico II), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Adriano Pellicelli(Carlo Forlanini Hospital), Giuliano Rizzardini, Elisabetta Teti(University of Rome Tor Vergata), Roberto Gulminetti(University of Pavia), C. Paternoster, Laura Ambra Nicolini(Ospedale Policlinico San Martino), Bianca Bruzzone(Ospedale Policlinico San Martino), Vincenza Calvaruso(University of Palermo), Stefania Paolucci(Policlinico San Matteo Fondazione), Maria Rendina, Simona Landonio(ASST Fatebenefratelli Sacco), M. Aragri(University of Rome Tor Vergata), Giovanni Cenderrello, C. Pasquazzi(Azienda Ospedaliera Sant'Andrea), Sergio Babudieri(University of Sassari), Ada Bertoli(IRCCS Policlinico San Donato), Ilaria Lenci, Ennio Polilli(Azienda USL di Pescara), Ivana Maida, Valeria Ghisetti(Ospedale Amedeo di Savoia), Vincenzo Sangiovanni(Ospedale Sant'Anna), Gloria Taliani(Sapienza University of Rome), Vanni Borghi(University of Modena and Reggio Emilia), Chiara Masetti(NHS Blood and Transplant), Teresa Pollicino(University of Messina), R. Ganga(Azienda Ospedaliera G. Brotzu), Alessia Ciancio(Department of Medical Sciences), Nunzia Cuomo(Federico II University Hospital), Pietro Andreoné, Valeria Micheli(ASST Fatebenefratelli Sacco), Stefano Novati(Policlinico San Matteo Fondazione), Maria Paola Callegaro, Maurizia Rossana Brunetto(University of Pisa), Raffaele Cozzolongo, Giulia Morsica(Vita-Salute San Raffaele University), Elisabetta Degasperi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), A. De Santis(Sapienza University of Rome), Teresa Santantonio(Ospedali Riuniti di Foggia), Carmine Minichini(University of Campania "Luigi Vanvitelli"), Silvia Barbaliscia(University of Rome Tor Vergata), Simona Marenco, Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Filomena Morisco, Valeria Pace Palitti(Azienda USL di Pescara), Valeria Cento(Rostov State Medical University)
Cited by 0
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2001|470